공고 • 14h
Inventurus Knowledge Solutions Limited to Report Q1, 2027 Results on Aug 05, 2026 Inventurus Knowledge Solutions Limited announced that they will report Q1, 2027 results on Aug 05, 2026 Reported Earnings • May 14
Full year 2026 earnings: Revenues and EPS in line with analyst expectations Full year 2026 results: EPS: ₹43.12 (up from ₹29.20 in FY 2025). Revenue: ₹32.1b (up 21% from FY 2025). Net income: ₹7.22b (up 48% from FY 2025). Profit margin: 23% (up from 18% in FY 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Healthcare Services industry in Asia. 공고 • May 05
Inventurus Knowledge Solutions Limited to Report Q4, 2026 Results on May 13, 2026 Inventurus Knowledge Solutions Limited announced that they will report Q4, 2026 results on May 13, 2026 Valuation Update With 7 Day Price Move • Apr 30
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹1,655, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Healthcare Services industry in Asia. Total returns to shareholders of 12% over the past year. Simply Wall St's valuation model estimates the intrinsic value at ₹736 per share. 공고 • Apr 16
Inventurus Knowledge Solutions Limited Debuts MyCareHub Agentic AI Platform Inventurus Knowledge Solutions Limited announce the groundbreaking launch of MyCareHub™, a proven agentic AI self-orchestrating platform that puts patients first and transforms how they engage with their healthcare journey before, during and after care, at the annual conference of the American Medical Group Association (AMGA) April 15-18. The novel care model, now integrated with Epic and available in the Epic Connection Hub, uses an active, aware and constant multi-agent behavioral algorithm to create a patient engagement operating system that is adaptive, autonomous and patient-first. MyCareHub uses behavioral modeling, longitudinal patient memory, decision intelligence, orchestration logic, safety guardrails and transparent autonomy controls to create a novel patient engagement platform that scores awareness of obligations, ability to meet them and willingness to do so. The channel, cadence and tone of reminders are personalized to drive adherence, ensuring quality care that ultimately lowers total cost of care. IKS Health implemented Recent year-over-year comparison data* from OrthoNY’s MyCareHub platform showed: 4.7% increase in total patient collections; 9.4% increase in patient payments per visit; 8.25% increase in net payments per visit. 공고 • Apr 13
Inventurus Knowledge Solutions Reportedly in Advanced Negotiations to Acquire TruBridge for $600 Million Inventurus Knowledge Solutions Limited (NSEI:IKS) is in advanced negotiations to acquire Nasdaq-listed TruBridge, Inc. (NasdaqGS:TBRG) in the US for around $600 million, said people aware of the matter. If the deal takes place, this will be the company's largest purchase and will help consolidate its presence in the healthcare solutions and revenue cycle management (RCM) segment, the people said. The transaction is in line with heightened investor interest in the space, which has seen unprecedented consolidation in the past two years. A formal announcement is expected in the coming days. IKS Healthcare, which gave the Jhunjhunwala family a 530-fold return on their investment during its December 2024 listing, is held by three discretionary trusts of the promoter family - Nishtha, Aryavir and Aryaman - with each owning 16.37% of the company. Rekha Jhunjhunwala, Rakesh's widow, owns another 0.23% stake while IKS founder Sachin Gupta holds 33.57%. The promoter group owns a total 63.7% of the company, which seeks to simplify administrative tasks of physicians and medical assistants. The company, founded originally as an RCM service provider in 2006, works with US providers. It manages their tasks as part of the overall care management process. These cover various customer touchpoints, ranging from scheduling to denial management. IKS added transcription service capabilities after its $200 million acquisition of Aquity Solutions in October 2023. This also brought in many client relationships, some of which can be scaled in the medium term. IKS is negotiating for $675 million in financing with Citi, Deutsche Bank and JP Morgan to back its all-cash offer as well as help refinance the target's debt, said the people cited. TruBridge also provides healthcare information technology and services to community hospitals and healthcare organisations. Reported Earnings • Feb 05
Third quarter 2026 earnings: EPS in line with expectations, revenues disappoint Third quarter 2026 results: EPS: ₹10.96 (up from ₹7.80 in 3Q 2025). Revenue: ₹8.21b (up 25% from 3Q 2025). Net income: ₹1.83b (up 41% from 3Q 2025). Profit margin: 22% (up from 20% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia. 공고 • Jan 27
Inventurus Knowledge Solutions Limited to Report Q3, 2026 Results on Feb 04, 2026 Inventurus Knowledge Solutions Limited announced that they will report Q3, 2026 results on Feb 04, 2026 Reported Earnings • Nov 01
Second quarter 2026 earnings: EPS and revenues exceed analyst expectations Second quarter 2026 results: EPS: ₹10.81 (up from ₹6.80 in 2Q 2025). Revenue: ₹7.85b (up 21% from 2Q 2025). Net income: ₹1.81b (up 60% from 2Q 2025). Profit margin: 23% (up from 17% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 8.0%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia. 공고 • Oct 15
Inventurus Knowledge Solutions Limited to Report First Half, 2026 Results on Oct 30, 2025 Inventurus Knowledge Solutions Limited announced that they will report first half, 2026 results on Oct 30, 2025 공고 • Sep 26
Inventurus Knowledge Solutions Limited Approves Board Appointments Inventurus Knowledge Solutions Limited at the Annual General Meeting held on September 23, 2025 approved appointment of Dr. Garheng Albert Kong as an Independent Director of the Company; Appointment of Mr. Sachin Gupta as a Director (Non-Executive, Non-Independent) of the Company; Appointment of Ms. Nithya Balasubramanian as the Whole-Time Director of the Company. 공고 • Aug 29
Inventurus Knowledge Solutions Limited, Annual General Meeting, Sep 23, 2025 Inventurus Knowledge Solutions Limited, Annual General Meeting, Sep 23, 2025, at 17:30 Indian Standard Time. Board Change • Aug 15
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Theresa Stone was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Aug 02
First quarter 2026 earnings released: EPS: ₹9.07 (vs ₹5.75 in 1Q 2025) First quarter 2026 results: EPS: ₹9.07 (up from ₹5.75 in 1Q 2025). Revenue: ₹7.40b (up 16% from 1Q 2025). Net income: ₹1.52b (up 59% from 1Q 2025). Profit margin: 21% (up from 15% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia. 공고 • Jul 24
Inventurus Knowledge Solutions Limited to Report Q1, 2026 Results on Jul 31, 2025 Inventurus Knowledge Solutions Limited announced that they will report Q1, 2026 results on Jul 31, 2025 Reported Earnings • May 16
Full year 2025 earnings: Revenues and EPS in line with analyst expectations Full year 2025 results: EPS: ₹29.20 (up from ₹22.37 in FY 2024). Revenue: ₹27.0b (up 49% from FY 2024). Net income: ₹4.86b (up 31% from FY 2024). Profit margin: 18% (down from 20% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia. 공고 • Apr 24
Inventurus Knowledge Solutions Limited to Report Q4, 2025 Results on May 15, 2025 Inventurus Knowledge Solutions Limited announced that they will report Q4, 2025 results on May 15, 2025 Valuation Update With 7 Day Price Move • Mar 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹1,447, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 21x in the Healthcare Services industry in Asia. Simply Wall St's valuation model estimates the intrinsic value at ₹874 per share. Reported Earnings • Feb 07
Third quarter 2025 earnings released Third quarter 2025 results: EPS: ₹7.80. Net income: ₹1.30b (up ₹1.30b from 3Q 2024). Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹1,568, the stock trades at a trailing P/E ratio of 72.2x. Average trailing P/E is 24x in the Healthcare Services industry in Asia. 공고 • Jan 17
Inventurus Knowledge Solutions Limited to Report Q3, 2025 Results on Feb 05, 2025 Inventurus Knowledge Solutions Limited announced that they will report Q3, 2025 results on Feb 05, 2025 Board Change • Dec 19
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Theresa Stone was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 
